| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DR beta 5 | 0.608 | 0.731 | 3.6E-07 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1979 | 2001 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
group | 0.100 | None | 0.940 | 50 | 1 | 1980 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
group | 0.100 | None | 0.900 | 10 | 0 | 1982 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1982 | 2017 | ||||||||
|
RNA binding region (RNP1, RRM) containing 3 | 0.608 | 0.731 | 2.0E-04 |
|
group | 0.080 | None | 0.875 | 8 | 0 | 1984 | 2018 | ||||||||
|
complement C4B (Chido blood group) | 0.603 | 0.808 | 0.83 |
|
group | 0.360 | None | 1.000 | 7 | 0 | 1984 | 2017 | ||||||||
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1984 | 2008 | ||||||||
|
complement component 4B (Chido blood group), copy 2 | 0.670 | 0.731 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1984 | 1994 | |||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
TNF receptor superfamily member 13B | 0.558 | 0.769 | 2.1E-15 |
|
group | 0.100 | None | 1.000 | 13 | 2 | 1986 | 2018 | ||||||||
|
major histocompatibility complex, class II, DO alpha | 0.509 | 0.808 | 3.0E-10 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1986 | 2017 | ||||||||
|
glucagon | 0.431 | 0.885 | 3.5E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1986 | 1986 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 0.963 | 187 | 1 | 1987 | 2020 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.400 | None | 1.000 | 64 | 0 | 1987 | 2019 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
group | 0.100 | None | 0.935 | 31 | 0 | 1987 | 2019 | ||||||||
|
small RNA binding exonuclease protection factor La | 0.612 | 0.692 | 9.0E-02 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1987 | 2018 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.100 | None | 0.989 | 88 | 0 | 1989 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 0.987 | 76 | 1 | 1989 | 2020 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
group | 0.400 | None | 0.974 | 39 | 0 | 1989 | 2020 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
group | 0.400 | None | 1.000 | 29 | 1 | 1989 | 2020 | ||||||||
|
heat shock protein family D (Hsp60) member 1 | 0.432 | 0.808 | 0.99 |
|
group | 0.100 | None | 0.909 | 22 | 0 | 1989 | 2019 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1989 | 2019 | ||||||||
|
DNA topoisomerase I | 0.542 | 0.692 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
ring finger protein 112 | 0.716 | 0.500 | 2.2E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 |